MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

S. Joza, M. Hu, KY. Jung, D. Kunz, D. Arnaldi, JY. Lee, L. Ferini-Strambi, E. Antelmi, F. Sixel-Döring, V. de Cock, J. Montplaisir, M. Lawton, HJ. Kim, F. Bes, P. Mattioli, K. Woo, S. Marelli, G. Plazzi, B. Mollenhauer, A. Pelletier, JS. Sunwoo, N. Girtler, C. Trenkwalder, JF. Gagnon, R. Postuma (Montreal, Canada)

Meeting: 2023 International Congress

Abstract Number: 369

Keywords: Cognitive dysfunction, Dementia with Lewy bodies (DLB), Parkinsonism

Category: Parkinson's Disease: Cognitive functions

Objective: To assess the progression and predictive value of neuropsychological testing on the development of dementia in idiopathic REM sleep behavior disorder (iRBD).

Background: iRBD is a powerful indicator of underlying synucleinopathy, with >80% developing an overt neurodegenerative disease, including DLB and PD. This provides an opportunity to directly observe the evolution of prodromal DLB and to identify which cognitive variables are the strongest predictors of developing dementia. This would enable more precise selection of subjects for future targeted therapies.

Method: iRBD subjects from 10 centers of the International RBD Study Group underwent annual neuropsychological assessment. Competing risk regression analysis determined optimal predictors of dementia. Linear mixed-effect models determined annual progression of neuropsychological testing.

Results: Subjects (n=754) were followed for 3.3 ± 2.4 years, and 170 phenoconverted to overt synucleinopathy: 96 PD and 74 DLB (Table 1). Reduced attention and executive function, particularly performance on the Trail Making Test part B, were the strongest identifiers of early DLB (HRs>4.5; Table 2). Prodromal cognitive changes in DLB started to emerge up to 10 years prior to phenoconversion, starting with decline in executive function followed by attention, then memory and visuospatial dysfunction closer to time of phenoconversion (Table 3, Fig. 1). Among specific tests, the Trail making test B and B-A appeared to be particularly useful as both the most sensitive tests for early DLB with the highest amplitude of change over time, while on longitudinal analysis, progression of memory impairment best distinguished dementia-first from parkinsonism-first phenoconversion.

Conclusion: The pathological processes that underlie cognitive dysfunction in iRBD can be detected very early in the disease course, prior to the motor manifestations of parkinsonism. In iRBD, attention and executive dysfunction strongly predict dementia and begin declining several years prior to phenoconversion.

Table1

Table2

Table3

Fig1

To cite this abstract in AMA style:

S. Joza, M. Hu, KY. Jung, D. Kunz, D. Arnaldi, JY. Lee, L. Ferini-Strambi, E. Antelmi, F. Sixel-Döring, V. de Cock, J. Montplaisir, M. Lawton, HJ. Kim, F. Bes, P. Mattioli, K. Woo, S. Marelli, G. Plazzi, B. Mollenhauer, A. Pelletier, JS. Sunwoo, N. Girtler, C. Trenkwalder, JF. Gagnon, R. Postuma. Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/prodromal-dementia-with-lewy-bodies-in-rem-sleep-behavior-disorder-a-multicenter-study/. Accessed June 12, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prodromal-dementia-with-lewy-bodies-in-rem-sleep-behavior-disorder-a-multicenter-study/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley